165 related articles for article (PubMed ID: 37522264)
41. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone.
Yamamoto A; Kumakura S; Uchida M; Barrett JC; Tsutsui T
Int J Cancer; 2003 Sep; 106(3):301-9. PubMed ID: 12845665
[TBL] [Abstract][Full Text] [Related]
42. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
Al-Khalaf HH; Hendrayani SF; Aboussekhra A
Mol Cancer Res; 2011 Mar; 9(3):311-9. PubMed ID: 21270107
[TBL] [Abstract][Full Text] [Related]
43. Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A.
McKenzie HA; Fung C; Becker TM; Irvine M; Mann GJ; Kefford RF; Rizos H
Hum Mutat; 2010 Jun; 31(6):692-701. PubMed ID: 20340136
[TBL] [Abstract][Full Text] [Related]
44. Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.
Becker TM; Rizos H; Kefford RF; Mann GJ
Clin Cancer Res; 2001 Oct; 7(10):3282-8. PubMed ID: 11595726
[TBL] [Abstract][Full Text] [Related]
45. The specific role of pRb in p16 (INK4A) -mediated arrest of normal and malignant human breast cells.
Bazarov AV; Lee WJ; Bazarov I; Bosire M; Hines WC; Stankovich B; Chicas A; Lowe SW; Yaswen P
Cell Cycle; 2012 Mar; 11(5):1008-13. PubMed ID: 22333593
[TBL] [Abstract][Full Text] [Related]
46. In vitro behavior and UV response of melanocytes derived from carriers of CDKN2A mutations and MC1R variants.
Hernando B; Swope VB; Guard S; Starner RJ; Choi K; Anwar A; Cassidy P; Leachman S; Kadekaro AL; Bennett DC; Abdel-Malek ZA
Pigment Cell Melanoma Res; 2019 Mar; 32(2):259-268. PubMed ID: 30117292
[TBL] [Abstract][Full Text] [Related]
47. The p16(INK4A) tumor suppressor regulates cellular oxidative stress.
Jenkins NC; Liu T; Cassidy P; Leachman SA; Boucher KM; Goodson AG; Samadashwily G; Grossman D
Oncogene; 2011 Jan; 30(3):265-74. PubMed ID: 20838381
[TBL] [Abstract][Full Text] [Related]
48. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
Kim LH; Peh SC; Poppema S
Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
[TBL] [Abstract][Full Text] [Related]
49. BRAFE600-associated senescence-like cell cycle arrest of human naevi.
Michaloglou C; Vredeveld LC; Soengas MS; Denoyelle C; Kuilman T; van der Horst CM; Majoor DM; Shay JW; Mooi WJ; Peeper DS
Nature; 2005 Aug; 436(7051):720-4. PubMed ID: 16079850
[TBL] [Abstract][Full Text] [Related]
50. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Schmidt M; Fan Z
Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
[TBL] [Abstract][Full Text] [Related]
51. Effect of extracts from Radix Ginseng, Radix Notoginseng and Rhizoma Chuanxiong on delaying aging of vascular smooth muscle cells in aged rats.
Tao LL; Lei Y; Wang GL; Zhu LQ; Wang Y
Chin J Integr Med; 2012 Aug; 18(8):582-90. PubMed ID: 22855034
[TBL] [Abstract][Full Text] [Related]
52. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
53. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
[TBL] [Abstract][Full Text] [Related]
54. p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways.
Steiner MS; Wang Y; Zhang Y; Zhang X; Lu Y
Oncogene; 2000 Mar; 19(10):1297-306. PubMed ID: 10713671
[TBL] [Abstract][Full Text] [Related]
55. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
[TBL] [Abstract][Full Text] [Related]
56. Contribution of p16(INK4a) to replicative senescence of human fibroblasts.
Brookes S; Rowe J; Gutierrez Del Arroyo A; Bond J; Peters G
Exp Cell Res; 2004 Aug; 298(2):549-59. PubMed ID: 15265701
[TBL] [Abstract][Full Text] [Related]
57. MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A.
Loercher AE; Tank EM; Delston RB; Harbour JW
J Cell Biol; 2005 Jan; 168(1):35-40. PubMed ID: 15623583
[TBL] [Abstract][Full Text] [Related]
58. The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments.
Witkiewicz AK; Knudsen KE; Dicker AP; Knudsen ES
Cell Cycle; 2011 Aug; 10(15):2497-503. PubMed ID: 21775818
[TBL] [Abstract][Full Text] [Related]
59. The interplay between p16 serine phosphorylation and arginine methylation determines its function in modulating cellular apoptosis and senescence.
Lu Y; Ma W; Li Z; Lu J; Wang X
Sci Rep; 2017 Jan; 7():41390. PubMed ID: 28120917
[TBL] [Abstract][Full Text] [Related]
60. Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions.
Jenkins NC; Jung J; Liu T; Wilde M; Holmen SL; Grossman D
J Invest Dermatol; 2013 Apr; 133(4):1043-51. PubMed ID: 23190892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
